Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Edgar Rodríguez-Wilson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Avenida Universidad No. 1001, Colonia Chamilpa, Cuernavaca 62209, Morelos, México. Hauptthemen laut MEDLINE: Monoamine Oxidase Inhibitors, Plant Extracts, Monoamine Oxidase, Depression. Die Arbeit nennt 26 Literaturangaben. Gefördert von: "Consejo Nacional de Ciencia y Tecnología" Ciencia Básica, FORDECYT-PRONACES, “Consejo Nacional de Ciencia y Tecnología” Ciencia Básica.
Abstract (Originalsprache)
Background
Agastache mexicana is used in traditional medicine to treat anxiety, insomnia, pain, among others. In a previous study, the methanolic extract exerted anxiolytic and sedative effects, as observed behaviorally, associated with one of its major components, tilianin.
Objective
To assess the effect produced by the extracts and tilianin obtained from Agastache mexicana on depressive-induced behavior model and on the activity of monoamine oxidases (MAOs).
Methods
The depression experimental model consisted of the forced swimming test in rats. MAOs activity was evaluated in cortex and hippocampus from the tilianin and Agastache extracts treated rats using specific inhibitors for each isoform. The quantification of monoamines was carried out using an High Performance Liquid Chromatography method.
Results
An increase in the swimming time was observed in rodents treated with doses of 16 (226.6 ± 5.5 seconds) and 50 mg/kg (237.8 ± 5.7 seconds) of tilianin, methanolic (260.4 ± 3 seconds), and hydroalcoholic extracts (249.6 ± 2.6 seconds) at 100 mg/kg. MAOs activity was significantly decreased in brain tissue from animals treated with 16 and 50 mg/kg of tilianin, methanolic, and hydroalcoholic extracts at 100 mg/kg.
Conclusions
The tilianin effect on monoamine oxidases inhibition is confirmed, suggesting its potential use in the treatment of certain neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Avenida Universidad No. 1001, Colonia Chamilpa, Cuernavaca 62209, Morelos, México.
- Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Avenida Insurgentes Sur No. 3877, Colonia La Fama, Alcaldía Tlalpan, Ciudad de México 14269, México.
- Laboratorio de química analítica, Unidad Académica Multidisciplinaria Reynosa-Aztlán Reynosa, Universidad Autónoma de Tamaulipas, calle 16 y lago de Chapala, Col. Aztlán, Reynosa 88740, Tamaulipas, México.
ORCID-Profile: Edgar Rodríguez-Wilson, Samuel Estrada-Soto
Förderung
- "Consejo Nacional de Ciencia y Tecnología" Ciencia Básica
- FORDECYT-PRONACES
- “Consejo Nacional de Ciencia y Tecnología” Ciencia Básica
Zitieren
APA
Rodríguez-Wilson, E., Estrada-Soto, S., Rubio-Osornio, M., Tristán-López, L., Navarrete-Vázquez, G., Gutiérrez-Hernández, A., & Montes, S. (2025). Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae117
Vancouver
Rodríguez-Wilson E, Estrada-Soto S, Rubio-Osornio M, Tristán-López L, Navarrete-Vázquez G, Gutiérrez-Hernández A, et al. Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae117
BibTeX
@article{RodrguezWilson2025,
author = {Rodríguez-Wilson, Edgar and Estrada-Soto, Samuel and Rubio-Osornio, Moisés and Tristán-López, Luis and Navarrete-Vázquez, Gabriel and Gutiérrez-Hernández, Abraham and Montes, Sergio},
title = {Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae117}
}
EUVIMED